M&T Bank’s Acceleron Pharma XLRN Stock Holding History

M&T Bank’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,403	Closed	-$242K	–	1648
2021 Q3	$242K	Sell	1,403 -231	-14%	-$30.2K	﹤0.01%	1354
2021 Q2	$205K	Sell	1,634 -20	-1%	-$2.52K	﹤0.01%	1455
2021 Q1	$223K	Sell	1,654 -165	-9%	-$21.3K	﹤0.01%	1369
2020 Q4	$232K	Buy	+1,819	New	+$213K	﹤0.01%	1453

M&T Bank's XLRN Position: Q4 2021 in Review

M&T Bank sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,403 shares — an estimated $242K sold.

M&T Bank first reported a position in XLRN in Q4 2020 and held it in 4 quarters. The position peaked at $242K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

M&T Bank reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
M&T Bank sold 1,403 Acceleron Pharma shares in Q4 2021, an estimated $242K.
M&T Bank first reported a position in Acceleron Pharma in Q4 2020 and held it in 4 quarters.
M&T Bank's Acceleron Pharma position peaked at $242K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on M&T Bank's 13F filing for Q4 2021, filed 7 Feb 2022.